INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Now Available Over the Counter, LASTACAFT® Provides Eye Allergy Itch Relief in Minutes that Lasts Through 16 Hours Pharmaceutical Investing
AbbVie and Scripps Research Announce Collaboration to Develop Antiviral Treatments for COVID-19 Pharmaceutical Investing
In Preparation for Launch of the Gummy Project, Potent Ventures Activates Partnership with OCEARCH Through a Matching Gift Campaign Designed to Inspire the Global Community Biotech Investing
Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin in Combination with Opdivo in Previously Untreated Unresectable or Metastatic Melanoma Pharmaceutical Investing
AUPH Investor Alert: ROSEN, A Top Ranked Law Firm, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
AUPH EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation - AUPH Pharmaceutical Investing
BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T. Company News
Bristol Myers Squibb to Report Results for First Quarter 2022 on April 29, 2022 Pharmaceutical Investing
